These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7356959)

  • 1. Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences.
    Laudano AP; Doolittle RF
    Biochemistry; 1980 Mar; 19(5):1013-9. PubMed ID: 7356959
    [No Abstract]   [Full Text] [Related]  

  • 2. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
    Doolittle RF; Pandi L
    Biochemistry; 2007 Sep; 46(35):10033-8. PubMed ID: 17688324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers.
    Laudano AP; Doolittle RF
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3085-9. PubMed ID: 277910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of fibrin polymerization by fragment d is affected by calcium, Gly-Pro-Arg and Gly-His-Arg.
    Furlan M; Rupp C; Beck EA
    Biochim Biophys Acta; 1983 Jan; 742(1):25-32. PubMed ID: 6824684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The subunit structure of lamprey fibrinogen and fibrin.
    Doolittle RF; Wooding GL
    Biochim Biophys Acta; 1974 Dec; 371(2):277-82. PubMed ID: 4474019
    [No Abstract]   [Full Text] [Related]  

  • 7. Equilibria in the fibrinogen-fibrin conversion. IX. Effects of calcium ions on the reversible polymerization of fibrin monomer.
    Endres GF; Scheraga HA
    Arch Biochem Biophys; 1972 Nov; 153(1):266-78. PubMed ID: 4675447
    [No Abstract]   [Full Text] [Related]  

  • 8. DIFFERENCES IN THE CLOTTING OF LAMPREY FIBRINOGEN BY LAMPREY AND BOVINE THROMBINS.
    DOOLITTLE RF
    Biochem J; 1965 Mar; 94(3):735-41. PubMed ID: 14340065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some symmetry considerations for the fibrinogen-fibrin assembly system.
    Doolittle RF
    J Supramol Struct; 1974; 2(2-4):138-49. PubMed ID: 4474572
    [No Abstract]   [Full Text] [Related]  

  • 10. X-ray crystallographic studies on fibrinogen and fibrin.
    Doolittle RF
    J Thromb Haemost; 2003 Jul; 1(7):1559-65. PubMed ID: 12871291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of peptides--structural analogs of NH2-terminal sites of fibrin alpha- and beta-chains--on specific binding of the NH2-terminal disulfide bond of fibrin with fibrinogen].
    Pozdniakova TM; Rybalchuk VN; Il'ina AV; Davidovich IuA; Rogozhin SV
    Ukr Biokhim Zh (1978); 1986; 58(2):10-5. PubMed ID: 3509954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of low-molecular peptides on the transformation of fibrinogen into fibrin].
    Levitskaia NG; Kleĭmenov AN; Petrosian MT; Rozenfel'd MA; Kalikhevich VN
    Biull Eksp Biol Med; 1987 Aug; 104(8):190-2. PubMed ID: 3620679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of native chicken fibrinogen at 2.7 A resolution.
    Yang Z; Kollman JM; Pandi L; Doolittle RF
    Biochemistry; 2001 Oct; 40(42):12515-23. PubMed ID: 11601975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of fibrinogen-binding tetrapeptides with fibrin oligomers and fine fibrin clots.
    Schindlauer G; Bale MD; Ferry JD
    Biopolymers; 1986 Jul; 25(7):1315-36. PubMed ID: 3741995
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of anti-beta 43-47 Fab fragments on expression of the polymerization sites in the E domain of fibrinogen.
    Cierniewski CS; Poniatowski J
    Acta Biochim Pol; 1990; 37(1):31-7. PubMed ID: 2087914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the factors contributing to fibrin-dependent plasminogen activation.
    Mosesson MW; Siebenlist KR; Voskuilen M; Nieuwenhuizen W
    Thromb Haemost; 1998 Apr; 79(4):796-801. PubMed ID: 9569195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-linking reactions of lamprey fibrinogen and fibrin.
    Murtaugh PA; Halver JE; Lewis MS; Gladner JA
    Biochim Biophys Acta; 1974 Aug; 359(2):415-20. PubMed ID: 4211896
    [No Abstract]   [Full Text] [Related]  

  • 18. The structural characteristics of chicken fibrinogen.
    Pindyck J; Mosesson MW; Bannerjee D; Galanakis D
    Biochim Biophys Acta; 1977 Jun; 492(2):377-86. PubMed ID: 884138
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthetic peptides modeled on fibrin polymerization sites.
    Laudano AP; Cottrell BA; Doolittle RF
    Ann N Y Acad Sci; 1983 Jun; 408():315-29. PubMed ID: 6575692
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence for four different polymerization sites involved in human fibrin formation.
    Olexa SA; Budzynski AZ
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1374-8. PubMed ID: 6929491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.